| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-13 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-11 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.21 | 4e-09 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-08 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |